Trulicity and Bydureon are the first once WEEKLY GLP-1 agonists

Trulicity (TRUE-lih-sih-tee, dulaglutide) and Bydureon (by-DUR-ee-on, exenatide ER) will be two new GLP-1 agonists for type 2 diabetes....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login